1. Home
  2. XELB vs REVB Comparison

XELB vs REVB Comparison

Compare XELB & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • REVB
  • Stock Information
  • Founded
  • XELB 2011
  • REVB 2020
  • Country
  • XELB United States
  • REVB United States
  • Employees
  • XELB N/A
  • REVB N/A
  • Industry
  • XELB Multi-Sector Companies
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • XELB Miscellaneous
  • REVB Health Care
  • Exchange
  • XELB Nasdaq
  • REVB Nasdaq
  • Market Cap
  • XELB 4.6M
  • REVB 3.8M
  • IPO Year
  • XELB N/A
  • REVB N/A
  • Fundamental
  • Price
  • XELB $1.66
  • REVB $2.79
  • Analyst Decision
  • XELB
  • REVB
  • Analyst Count
  • XELB 0
  • REVB 0
  • Target Price
  • XELB N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • XELB 93.5K
  • REVB 212.9K
  • Earning Date
  • XELB 08-13-2025
  • REVB 08-08-2025
  • Dividend Yield
  • XELB N/A
  • REVB N/A
  • EPS Growth
  • XELB N/A
  • REVB N/A
  • EPS
  • XELB N/A
  • REVB N/A
  • Revenue
  • XELB $7,407,000.00
  • REVB N/A
  • Revenue This Year
  • XELB $23.96
  • REVB N/A
  • Revenue Next Year
  • XELB $53.02
  • REVB N/A
  • P/E Ratio
  • XELB N/A
  • REVB N/A
  • Revenue Growth
  • XELB N/A
  • REVB N/A
  • 52 Week Low
  • XELB $1.51
  • REVB $2.11
  • 52 Week High
  • XELB $8.49
  • REVB $168.00
  • Technical
  • Relative Strength Index (RSI)
  • XELB 39.57
  • REVB 42.76
  • Support Level
  • XELB $1.51
  • REVB $2.20
  • Resistance Level
  • XELB $1.80
  • REVB $2.92
  • Average True Range (ATR)
  • XELB 0.16
  • REVB 0.27
  • MACD
  • XELB 0.01
  • REVB 0.26
  • Stochastic Oscillator
  • XELB 30.58
  • REVB 88.01

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: